Modified yeasts could be used to produce alkaloid drugs Yeast has been genetically modified to make (S)-reticuline, a precursor to a wide range of therapeutic alkaloids. The work marks an important step towards producing such pharmaceuticals by fermentation.…
Pharmaceutical fakes: a dangerous pandemic A unified authentication system is needed to combat the massive trade in counterfeit medicines. …
Chris McGuigan: driving drug development Chris McGuigan, chairman of the Life Sciences Hub Wales, discusses the business side of research, his proudest invention and what the future holds for innovation in Wales.…
How to manage staff and other pharmacy colleagues Most pharmacy jobs will involve managing other people to some degree. Ailsa Colquhoun finds out how to get the most from those around you.…
EMA takes on responsibility for screening medical literature for ADRsThe European Medicines Agency has taken over responsibility for screening the medical literature for suspected adverse drug reactions associated with certain drug substances.…
Technicians are seeking powers that would threaten patient safety, claims PDA A row is brewing between pharmacists and technicians about the potential tasks pharmacy technicians can perform unsupervised when the pharmacist is away from the workplace.…
Drug development: the journey of a medicine from lab to shelf Before a drug is deemed suitable for patients, it has to go through rigorous testing and cost-effectiveness analyses.…
European Medicines Agency tightens conflict of interest rules for its expert advisersEurope’s medicines safety regulator has tightened up its conflict of interest rules for scientific committee members and expert advisers in updated policy guidance.…
First treatment for blind people with rare sleep disorder gets the go-ahead in Europe A drug to treat a rare sleep disorder almost exclusively affecting blind people has been recommended for authorisation by the European Medicines Agency.…
Hepatitis C drugs hit by incompatibility warnings Gilead’s hepatitis C drugs Harvoni and Sovaldi and Bristol-Myers Squibb’s Daklinza have been hit by warnings from drug regulators regarding their incompatibility with amiodarone.…